¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ) The Liver Week 2020 Virtual Confernence Day 1 : 2020-08-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ) The Liver Week 2020 Virtual Confernence Day 1 : 2020-08-13
±³À°ÀÏÀÚ : 2020-08-13
±³À°Àå¼Ò : ¿Â¶óÀÎ Çмú´ëȸ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) The Liver Week 2020 Virtual Confernence Day 1      
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ
¿¬¶ôó : 02-707-0091  
À̸ÞÀÏ : kasl@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã 
±³À°½Ã°£ : 11 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í Member-KRW 50,000/Resident, Trainee, Nurse, Army Doctor, Others-KRW 30,000Non-Member, Healthcare Professional-KRW 60,000      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:00~09:20 Pharmacological Treatment of Alcoholic Hepatitis  Gyongyi Szabo(Harvard Univ. USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:20~09:40 Pharmacological Treatment of Nonalcoholic Steatohepatitis  Manal Abdelmalek(Duke Univ. USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:40~10:00 New Horizon of Immuno-Oncologic Therapy  Amit Singal(Univ. of Texas Southwestern USA) 
Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:00~10:10 Discussion  () 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:05~09:25 Obesity and Alcohol Are Deadly Combination to Induce Steatohepatitis  Bin Gao(National Institutes of Health USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:25~09:45 Alcohol-NAFLD Interactions  Kenichi Ikejima(Juntendo Univ. Japan) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 09:45~10:05 Autophagy Regulation in Alcoholic and Non-Alcoholic Liver Steatosis  Sang Geon Kim(Seoul National Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:05~10:25 Alcohol-NAFLD Interactions in a Large Korean Cohort Study  Yong Kyun Cho(Sungkyunkwan Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:25~10:35 Interaction between CD40L and CD40 Mediates Hepatic Exosomal Delivery to Kupffer Cells in Alcoholic Liver Disease  Kyurae Kim(KAIST) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:35~10:45 The Effect of Intestinal Flora Modification on Alcoholic Liver Injury in Obese KK-Ay Mice  Kazuyoshi Kon(Juntendo Univ. Japan) 
Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:45~11:00 Round Table Discussions  () 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 10:20~11:20 Plenary Presentation 1  Kwan Sik Lee Kwan Soo Byun Ho Seong Han(Yonsei Univ Korea Univ Seoul National Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:00~11:20 Neuroendocrine-Fat-Liver Axis  Laura E. Nagy(Cleveland Clinic USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:20~11:40 Lymphatic System and Organ Crosstalk  Yasuko Iwakiri(Yale Univ. USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:40~12:00 Liver-Lung Crosstalk  Gavin E. Arteel(Univ. of Pittsburgh USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:00~12:20 Glutamate/mGluR5-mediated Endocannabinoid in Alcoholic Fatty Liver  Won-IL Jeong(KAIST) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:20~12:30 CYP2E1 Regulation of Ethanol-Induced Intestinal miRNAs in Liver Injury  Je-Hyun Yoon(Medical Univ. of South Carolina USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:30~12:40 Chronic Alcohol Consumption Alters the Phenotype of F4/80+CD11b+ Bone Marrow Cells by Neuro-Metabolic Signaling Pathway  Young-Ri Shim(KAIST) 
Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 12:40~13:00 Round Table Discussions  () 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 11:30~12:00 Past, Present, and Future of Precision Hepatology: Where Do We Need to Go?  W. Ray Kim(Stanford Univ. USA) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:00~13:20 Current Evidences and Future Perspectives for the Treatment of Advanced Hepatocellular Carcinoma  Jeong Won Jang(The Catholic Univ. of Korea) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:20~13:40 When Should We Consider Systemic Therapy in BCLC Stage B Hepatocellular Carcinoma?  Hyung Joon Yim(Korea Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:40~14:00 Therapeutic Efficacy of Transarterial-Based Treatment vs. Targeted Therapy in Advanced Hepatocellular Carcinoma  Sadahisa Ogasawara(Chiba Univ. Japan) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:00~14:20 Optimizing Therapeutic Efficacy with Systemic Treatment and Radiotherapy in Hepatocellular Carcinoma  Jinsil Seong(Yonsei Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:20~14:30 Discussion  () 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 13:50~14:40 General Oral Presentation 1 (*K)  Byung Ik Kim(Sungkyunkwan Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:40~14:55 Current Approaches to the Treatment of Early HCC in Japan  Naoshi Nishida(Kindai Univ. Japan) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 14:55~15:10 Current Approaches to the Treatment of Early HCC in Korea  Myeong Jun Song(The Catholic Univ. of Korea) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:10~15:25 Selection of Particle Beam vs. Photon Beam Radiation Therapy for HCC: Japanese Experience  Do Young Kim(Yonsei Univ) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:25~15:40 Selection of Particle Beam vs. Photon Beam Radiation Therapy for HCC: Korean Experience  Hee Chul Park(Sungkyunkwan Univ) 
Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 15:40~15:50 Discussion  () 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:00~16:20 Exploring Unrecognized Risks in Immune Tolerant Phase of Chronic Hepatitis B  Young-Suk Lim(Univ. of Ulsan) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:20~16:40 Clonal Hepatocyte Expansion and Hepatitis B Virus Integration  Patrick Kennedy(Queen Mary Univ. of London UK) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 16:40~17:00 Effect of Current and Novel Antivirals on the Prevention of Hepatocellular Carcinoma: Beyond Viral Suppression  George V. Papatheodoridis(National and Kapodistrian Univ. of Athens Greece) 
±³À°½Ã°£ 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 17:00~17:20 Functional Cure of Chronic Hepatitis B and Beyond  Man-Fung Yuen(The Univ. of Hong Kong Hong Kong) 
Åä·Ð 08¿ù 13ÀÏ ¿Â¶óÀÎ Çмú´ëȸ 17:20~17:30 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ) The Liver Week 2020 Virtual Confernence Day 1 : 2020-08-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ±¹°¡»ý¸íÀ±¸®Á¤Ã¥¿ø Á¦5Â÷ ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»¡¤½ÉÈ­±³À° : 2020-08-14
´ÙÀ½±Û ´ëÇÑ°³¿ø³»°úÀÇ»çȸ 2020³â Á¦2ȸ ÃÊÀ½Æı³À° : 2020-08-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
15 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-29 0 690 2018-07-28
14 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø ¿µ»óȹµæÀÇ ±â¼úÀû Ãø¸é°ú Æó¾Ï °ËÁø : 2018-07-29 0 737 2018-07-28
13 ¼­¿ï ´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29 0 861 2018-07-28
12 ¼­¿ï ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(7¿ù29ÀÏ) : 2018-07-29 0 796 2018-07-28
11 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-29 0 813 2018-07-28
10 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 18 ȸ ü°èÀû ¹®Çå °íÂû[¸ÞŸºÐ¼®]À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2018-07-28 0 1,146 2018-07-28
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,109 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,062 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 985 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,226 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,514 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,392 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,201 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,425 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,977 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷